Alder Biopharmaceuticals Inc. | TalkMarkets

Latest Posts

Healthcare & Biotechs Struggle, But Opportunity Ahead

Article By: Tarun Chandra, CFA

Wednesday, October 23, 2019 2:24 AM EDT

Improving risk appetite is nudging markets higher, and biotechs will participate as well, although gains will have a ceiling.

In this article: ACAD, ARQL, MNTA, SGEN, MDCO, ARWR, KPTI, RDUS, FLXN, RETA, ZYME, DRNA, TCDA, DCPH, APLS, ACHN, ALXN, VRTX, ALDR, RARX, DOVA

Read

Stocks For You To Swing-Trade: ALDR, TMO, HDP

Article By: Ryan Mallory

Tuesday, August 7, 2018 4:17 AM EDT

Tuesday's swing-trades: Alder Biopharmaceuticals, Thermo Fisher Scientific and Hortonworks.

In this article: TMO, ALDR, HDP

Read

Morning Call For Wednesday, July 12

Article By: Jim Van Meerten

Wednesday, July 12, 2017 8:07 AM EDT

Sep E-mini S&Ps (ESU17 +0.20%) this morning are up +0.18% and European stocks are up +0.78% as energy stocks climb with the price of Aug WTI crude oil (CLQ17 +1.60%) up +1.62%.

In this article: AIR, UAL, ARNA, CASY, COHU, HCSG, NVDA, SEAS, ALDR, KIN, OCUL

Read

IPO Preview: Biohaven Pharmaceuticals

Article By: Don Dion

Wednesday, May 3, 2017 7:55 AM EDT

Biohaven Pharmaceuticals expects to raise $112.6 million in its upcoming IPO ($130.1 million if the underwriters exercise their option to purchase additional shares).

In this article: WFC, LLY, CLCD, AGN, ALDR, AMGN, SHPG

Read